TB-500 and Employer Benefits: Insurance, ICHRA, HSA, and FSA Explained
Four benefits that are often confused
Employer-sponsored insurance pays covered claims under a policy. An individual coverage health reimbursement arrangement, commonly called an ICHRA, is employer-funded and can reimburse qualifying individual insurance premiums and, depending on its terms, other eligible medical expenses. It is not itself a drug formulary. [1]
An HSA is a tax-favored account associated with qualifying health coverage. A health FSA is an employer-established reimbursement arrangement. Both have qualified-expense rules, but their funding, ownership, and administration differ. IRS Publication 969 describes those distinctions. [2]
| Benefit | Main question | Evidence that is insufficient by itself |
|---|---|---|
| Health insurance | Is this product and indication covered? | A clinic's monthly subscription price |
| ICHRA | Does this expense meet the arrangement's terms? | Being enrolled in individual insurance |
| HSA | Is the distribution for a qualified expense? | A debit-card transaction that cleared |
| Health FSA | Is the expense eligible and substantiated? | A receipt containing a diagnosis code |
Why TB-500 needs a separate drug-status analysis
TB-500 is a name associated with a thymosin beta-4 fragment. A pharmacy license, a clinician's recommendation, and eligibility of a bulk ingredient are separate matters. FDA's section 503A framework imposes ingredient requirements in addition to a prescription. [3]
Research on a related peptide does not settle the benefit question either. The frequently cited healthy-volunteer study used full-length intravenous thymosin beta-4, not an employer-funded TB-500 recovery program. It measured early safety and pharmacokinetics, not a reimbursable treatment benefit. [4]
What a letter of medical necessity can and cannot do
A letter can explain a diagnosis and why a proposed expense relates to it. It cannot override the governing tax rules, the plan's terms, or drug law. IRS Publication 502 excludes illegal treatments from deductible medical expenses. Publication 969 supplies the rules for tax-favored accounts, including differences from the itemized deduction. [2,5]
This distinction also prevents a common mistake: applying Publication 502's prescription-drug deduction language to every over-the-counter HSA or FSA purchase. The account rules allow qualifying over-the-counter medicines without a prescription. That does not make an investigational peptide an ordinary over-the-counter medicine.
Frequently asked questions
Does a bundled clinic subscription prove TB-500 is reimbursable?
No. A bundle may contain different services and products with different eligibility. Its marketing description does not establish the status of each charge.
Can an employer choose to cover anything?
An employer can define benefits within applicable rules. Calling a payment a health benefit does not automatically make it tax-free or make the underlying product permissible.
What is useful to ask a benefits administrator?
Ask about the written rules for the actual diagnosed condition and established care options. A general statement that the plan covers prescriptions is not a product-specific decision.
